Inflammation-associated genes: risks and benefits to Foxp3(+) regulatory T-cell function

Richard A O'Connor, Stephen M Anderton

Research output: Contribution to journalLiterature reviewpeer-review

Abstract / Description of output

Foxp3(+) regulatory T (Treg) cells prevent the development of autoimmunity and immunopathology, as well as maintaining homeostasis and tolerance to commensal microorganisms. The suppressive activity of Treg cells is their defining characteristic, generating great interest in their therapeutic potential. However, suppressive and effector functions are not entirely exclusive. Considerable evidence points to the ability of supposedly anti-inflammatory Foxp3-expressing Treg cells to also express transcription factors that have been characterized as cardinal drivers of T effector cell function. We will consider the mounting evidence that Treg cells can function in non-suppressive capacities and review the impetus for this functional change, its relevance to developing immune and autoimmune responses and its significance to the development of Treg-based therapies.

Original languageEnglish
Pages (from-to)194-205
Number of pages12
Issue number2
Publication statusPublished - Oct 2015


Dive into the research topics of 'Inflammation-associated genes: risks and benefits to Foxp3(+) regulatory T-cell function'. Together they form a unique fingerprint.

Cite this